• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

关于女性骨矿物质密度及骨质疏松症/骨质减少与血管钙化之间关联的系统评价和荟萃分析。

Systematic review and meta-analysis for the association of bone mineral density and osteoporosis/osteopenia with vascular calcification in women.

作者信息

Zhang Yiyun, Feng Bo

机构信息

Department of Endocrinology, Shanghai East Hospital, Tongji University School of Medicine, Shanghai, 200120, China.

出版信息

Int J Rheum Dis. 2017 Feb;20(2):154-160. doi: 10.1111/1756-185X.12842. Epub 2016 May 6.

DOI:10.1111/1756-185X.12842
PMID:27153243
Abstract

AIM

The relationships of osteoporosis/osteopenia and bone mineral density (BMD) with vascular calcification (VC) remain controversial. Thus, we performed this systematic review and meta-analysis to evaluate the association between BMD, osteoporosis/osteopenia risk and VC.

METHODS

PubMed, Embase and Springer databases were searched from inception to March, 2015 for studies involving the association of vascular calcification with BMD and osteopenia/osteoporosis in women. A manual search of the references cited in the publications was also employed for more relevant studies. The heterogeneity was assessed using Cochran's Q statistic and I test. Weighted mean difference (WMD) or odds ratio (OR) and 95% confidence interval (CI) in the VC group and control group were appropriately pooled.

RESULTS

Four studies were enrolled in the meta-analysis. The pooled effects indicated that the spine BMD (WMD = -0.08, 95% CI: -0.11 to -0.06) and hip BMD (WMD = -0.06, 95% CI: -0.10 to -0.07) in VC group were significantly lower than those in control group, respectively. Moreover, patients with VC were prone to develop osteoporosis (OR = 4.39, 95% CI: 2.82-6.83) and osteopenia (OR = 1.72, 95% CI: 1.14-2.60).

CONCLUSION

The results suggest that patients with VC have lower lumbar spine and hip BMD levels and increased risk for developing osteoporosis/osteopenia. Thus, VC patients should be evaluated for the presence of osteoporosis/osteopenia, as well as susceptibility to fractures.

摘要

目的

骨质疏松症/骨质减少与骨密度(BMD)和血管钙化(VC)之间的关系仍存在争议。因此,我们进行了这项系统评价和荟萃分析,以评估骨密度、骨质疏松症/骨质减少风险与血管钙化之间的关联。

方法

检索了PubMed、Embase和Springer数据库,从数据库建立至2015年3月,查找涉及女性血管钙化与骨密度及骨质减少/骨质疏松症关联的研究。还对手册中出版物引用的参考文献进行了人工检索,以获取更多相关研究。使用Cochran's Q统计量和I检验评估异质性。对血管钙化组和对照组的加权平均差(WMD)或比值比(OR)及95%置信区间(CI)进行适当合并。

结果

四项研究纳入了荟萃分析。汇总效应表明,血管钙化组的脊柱骨密度(WMD = -0.08,95%CI:-0.11至-0.06)和髋部骨密度(WMD = -0.06,95%CI:-0.10至-0.07)分别显著低于对照组。此外,血管钙化患者更容易发生骨质疏松症(OR = 4.39,95%CI:2.82 - 6.83)和骨质减少(OR = 1.72,95%CI:1.14 - 2.60)。

结论

结果表明,血管钙化患者的腰椎和髋部骨密度水平较低,发生骨质疏松症/骨质减少的风险增加。因此,应对血管钙化患者进行骨质疏松症/骨质减少的评估以及骨折易感性的评估。

相似文献

1
Systematic review and meta-analysis for the association of bone mineral density and osteoporosis/osteopenia with vascular calcification in women.关于女性骨矿物质密度及骨质疏松症/骨质减少与血管钙化之间关联的系统评价和荟萃分析。
Int J Rheum Dis. 2017 Feb;20(2):154-160. doi: 10.1111/1756-185X.12842. Epub 2016 May 6.
2
Bone mineral density is decreased in fibromyalgia syndrome: a systematic review and meta-analysis.纤维肌痛综合征患者的骨矿物质密度降低:一项系统评价与荟萃分析。
Rheumatol Int. 2017 Apr;37(4):617-622. doi: 10.1007/s00296-016-3625-x. Epub 2016 Dec 5.
3
Bone Density and Clinical Periodontal Attachment in Postmenopausal Women: A Systematic Review and Meta-Analysis.绝经后女性的骨密度与临床牙周附着:一项系统评价与荟萃分析
J Dent Res. 2017 Mar;96(3):261-269. doi: 10.1177/0022034516682017. Epub 2017 Jan 3.
4
Bone mineral density in children and young adults with idiopathic scoliosis: a systematic review and meta-analysis.特发性脊柱侧弯儿童和年轻成人的骨密度:一项系统评价和荟萃分析。
Eur Spine J. 2023 Jan;32(1):149-166. doi: 10.1007/s00586-022-07463-w. Epub 2022 Dec 1.
5
Strontium ranelate for preventing and treating postmenopausal osteoporosis.雷奈酸锶用于预防和治疗绝经后骨质疏松症。
Cochrane Database Syst Rev. 2006 Jul 19(3):CD005326. doi: 10.1002/14651858.CD005326.pub2.
6
Progressive high-intensity resistance training and bone mineral density changes among premenopausal women: evidence of discordant site-specific skeletal effects.绝经前女性进行渐进性高强度抗阻训练与骨矿物质密度变化:不同部位骨骼效应不一致的证据
Sports Med. 2006;36(8):683-704. doi: 10.2165/00007256-200636080-00005.
7
The prevalence of osteoporosis, osteopenia, and fractures among adults with cystic fibrosis: a systematic literature review with meta-analysis.囊性纤维化成人骨质疏松症、低骨量和骨折的患病率:系统文献回顾和荟萃分析。
Calcif Tissue Int. 2010 Jan;86(1):1-7. doi: 10.1007/s00223-009-9316-9. Epub 2009 Dec 1.
8
Bone density and fracture risk factors in ankylosing spondylitis: a meta-analysis.强直性脊柱炎的骨密度和骨折危险因素:荟萃分析。
Osteoporos Int. 2024 Jan;35(1):25-40. doi: 10.1007/s00198-023-06925-1. Epub 2023 Oct 9.
9
Glucocorticoid-induced osteoporosis: a systematic review and cost-utility analysis.糖皮质激素性骨质疏松症:一项系统评价与成本效用分析
Health Technol Assess. 2007 Mar;11(7):iii-iv, ix-xi, 1-231. doi: 10.3310/hta11070.
10
Risedronate for the primary and secondary prevention of osteoporotic fractures in postmenopausal women.利塞膦酸钠用于绝经后妇女骨质疏松性骨折的一级和二级预防。
Cochrane Database Syst Rev. 2022 May 3;5(5):CD004523. doi: 10.1002/14651858.CD004523.pub4.

引用本文的文献

1
Considerations on the Development of Therapeutics in Vascular Calcification.关于血管钙化治疗学发展的思考
J Cardiovasc Dev Dis. 2025 May 29;12(6):206. doi: 10.3390/jcdd12060206.
2
Role of denosumab in lipid metabolism disorders: clinical significance and potential mechanisms.地诺单抗在脂质代谢紊乱中的作用:临床意义及潜在机制
Arch Osteoporos. 2025 May 26;20(1):68. doi: 10.1007/s11657-025-01546-z.
3
The Complex Mechanisms and the Potential Effects of Statins on Vascular Calcification: A Narrative Review.他汀类药物对血管钙化的复杂机制及潜在影响:一项叙述性综述
Rev Cardiovasc Med. 2024 Jan 30;25(2):51. doi: 10.31083/j.rcm2502051. eCollection 2024 Feb.
4
Zinc Action in Vascular Calcification.锌在血管钙化中的作用。
Prev Nutr Food Sci. 2024 Jun 30;29(2):118-124. doi: 10.3746/pnf.2024.29.2.118.
5
MicroRNAs regulate the vicious cycle of vascular calcification-osteoporosis in postmenopausal women.微小 RNA 调控绝经后妇女血管钙化-骨质疏松恶性循环。
Mol Biol Rep. 2024 May 6;51(1):622. doi: 10.1007/s11033-024-09550-1.
6
Humoral and cellular factors inhibit phosphate-induced vascular calcification during the growth period.在生长期间,体液和细胞因子可抑制磷酸盐诱导的血管钙化。
J Clin Biochem Nutr. 2023 Nov;73(3):198-204. doi: 10.3164/jcbn.23-11. Epub 2023 Jun 28.
7
Vascular deficits contributing to skeletal fragility in type 1 diabetes.导致1型糖尿病患者骨骼脆弱的血管缺陷。
Front Clin Diabetes Healthc. 2023 Oct 6;4:1272804. doi: 10.3389/fcdhc.2023.1272804. eCollection 2023.
8
Relationship between ectopic calcifications and bone fragility depicted on computed tomography scan in 70 patients with systemic sclerosis.70例系统性硬化症患者计算机断层扫描显示的异位钙化与骨脆性之间的关系
J Scleroderma Relat Disord. 2022 Oct;7(3):224-233. doi: 10.1177/23971983221104415. Epub 2022 Jun 28.
9
Aged bone matrix-derived extracellular vesicles as a messenger for calcification paradox.衰老骨基质衍生细胞外囊泡作为钙化悖论的信使。
Nat Commun. 2022 Mar 18;13(1):1453. doi: 10.1038/s41467-022-29191-x.
10
Machine Learning to Predict the Progression of Bone Mass Loss Associated with Personal Characteristics and a Metabolic Syndrome Scoring Index.机器学习用于预测与个人特征及代谢综合征评分指数相关的骨质流失进展情况。
Healthcare (Basel). 2021 Jul 28;9(8):948. doi: 10.3390/healthcare9080948.